Medical research
Unveiling the non-canonical functions of EZH2 in prostate cancer
A new editorial paper was published in Oncotarget titled "Unveiling the non-canonical functions of EZH2 in prostate cancer."
Mar 3, 2023
0
3
Oncogene
Medical research
New molecular blocker halts breast cancer metastasis, says study
An estimated ninety percent of deaths from breast cancer are due to complications resulting from metastasis, a process in which cancer cells break away from where they first formed, travel through the blood or lymph circulatory ...
Jan 17, 2023
0
22
Oncology & Cancer
Research identifies new way to halt pancreatic cancer invasion by targeting healthy cells
Researchers from Barts Cancer Institute at Queen Mary University of London have identified a new channel of communication through which non-cancerous cells drive the invasion of cancer cells in pancreatic cancer.
Nov 10, 2022
0
116
Oncology & Cancer
Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance
A recent study published in Oncogene and led by Dr. Sun Yu's group at Shanghai Institute of Nutrition and Health (SINH) of the Chinese Academy of Sciences revealed the roles and functional mechanisms of senescence-associated ...
Oct 25, 2022
0
7
Oncology & Cancer
A new drug target for triple-negative breast cancer
Research led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studies, reports a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy ...
Oct 17, 2022
0
10
Medical research
Researchers turn cancer cells into less harmful cell types
Cancer occurs when cells grow uncontrollably and spread to other organs in the body. Cancer cells differ from normal cells in many ways. One characteristic of cancer cells is their high adaptability to different environments ...
Sep 21, 2022
0
78
Oncology & Cancer
Enzyme inhibitor slows tumor growth
Together with researchers from University Hospital Mainz, the University of Regensburg and the IRCM in Montreal (Canada), a research team from Friedrich Schiller University Jena has discovered a novel therapeutic approach ...
Sep 21, 2022
0
4
Oncology & Cancer
Molecular mechanisms regulating prostate cancer hypoxia identified
A Northwestern Medicine study has identified a molecular mechanism that helps regulate the progression of castration-resistant prostate cancer, according to findings published in the journal Oncogene.
Sep 5, 2022
0
995
Medical research
Sugar chains on cell surfaces direct cancer cells to die
A cytokine named TRAIL binds to TRAIL receptors and kills cancer cells, but not normal cells. Various anticancer drugs targeting TRAIL receptors have been developed and gained great attention as a promising cancer therapeutics, ...
Aug 15, 2022
0
8
Oncology & Cancer
Interplay of genes: The understudied transcription factor RFX7 has a central role in growth and cancer
Proteins that are frequently altered in tumors play a prominent role in cancer research. The protein RFX7, a largely unknown transcription factor, has recently been linked to lymph node cancer. Researchers at the Leibniz ...
Jul 19, 2022
0
7
